Condition: Cancer · Sponsor: University of Calgary
The goal of this study is to understand if the implementation of a remote symptom monitoring and management program improves outcomes. The program will provide patients the opportunity to complete electronic Patient Reported Outcomes (PROs) questionnaires from home between appointments and receive tailored advice from a study nurse. A second goal of this study is to examine the impact of electronic symptom monitoring on clinic efficiencies. The main question it aims to answer is: • What impact does implementing digitally enabled remote symptom monitoring and management (RESPONd) between ambulatory oncology visits have on patient outcomes and system efficiencies? Participants will: * Report their symptoms and concerns from home by completing the electronic symptom monitoring questionnaire. * Discuss their symptoms and concerns with a study nurse. * Provide feedback about their experience at important timepoints during the study. * Participate as usual in ambulatory clinic appointments.
This description comes directly from the study's public registry record.
Chizoba Anyimukwu, MPH, DrPH · 587-943-3556 · chizoba.anyimukwu@albertahealthservices.ca
Benedicta Asante, RSW, MSW · 587-943-3562 · benedicta.asante@albertahealthservices.ca
Always discuss trial participation with your own doctor first.
| Arthur J. E. Child Comprehensive Cancer Centre | Calgary, Alberta, Canada | Recruiting |
| Cross Cancer Institute | Edmonton, Alberta, Canada | Recruiting |
| High River Community Cancer Centre | High River, Alberta, Canada | Not Yet Recruiting |
| Central Alberta Cancer Centre | Red Deer, Alberta, Canada | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07024329